Cumberland Pharmaceuticals Inc (CPIX)
1.20
+0.06
(+5.26%)
USD |
NASDAQ |
Nov 05, 16:00
1.20
0.00 (0.00%)
After-Hours: 16:16
Cumberland Pharmaceuticals Total Assets (Quarterly): 78.52M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 78.52M |
March 31, 2024 | 81.51M |
December 31, 2023 | 81.78M |
September 30, 2023 | 87.75M |
June 30, 2023 | 89.38M |
March 31, 2023 | 89.47M |
December 31, 2022 | 92.93M |
September 30, 2022 | 90.78M |
June 30, 2022 | 92.52M |
March 31, 2022 | 96.70M |
December 31, 2021 | 84.46M |
September 30, 2021 | 87.57M |
June 30, 2021 | 88.85M |
March 31, 2021 | 93.35M |
December 31, 2020 | 96.46M |
September 30, 2020 | 96.01M |
June 30, 2020 | 97.52M |
March 31, 2020 | 97.42M |
December 31, 2019 | 104.55M |
September 30, 2019 | 103.77M |
June 30, 2019 | 107.55M |
March 31, 2019 | 114.62M |
December 31, 2018 | 112.69M |
September 30, 2018 | 87.43M |
June 30, 2018 | 90.44M |
Date | Value |
---|---|
March 31, 2018 | 91.09M |
December 31, 2017 | 93.23M |
September 30, 2017 | 90.35M |
June 30, 2017 | 87.80M |
March 31, 2017 | 91.86M |
December 31, 2016 | 93.40M |
September 30, 2016 | 91.07M |
June 30, 2016 | 87.89M |
March 31, 2016 | 89.21M |
December 31, 2015 | 91.92M |
September 30, 2015 | 92.06M |
June 30, 2015 | 92.92M |
March 31, 2015 | 92.19M |
December 31, 2014 | 95.41M |
September 30, 2014 | 93.90M |
June 30, 2014 | 93.47M |
March 31, 2014 | 91.11M |
December 31, 2013 | 87.61M |
September 30, 2013 | 91.91M |
June 30, 2013 | 95.47M |
March 31, 2013 | 98.28M |
December 31, 2012 | 98.59M |
September 30, 2012 | 96.93M |
June 30, 2012 | 95.38M |
March 31, 2012 | 94.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
78.52M
Minimum
Jun 2024
104.55M
Maximum
Dec 2019
90.92M
Average
90.78M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.925M |
Palatin Technologies Inc | 10.74M |
iBio Inc | 28.73M |
Theriva Biologics Inc | 42.39M |
Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 52.49M |
Shareholders Equity (Quarterly) | 26.35M |
Debt to Equity Ratio | 0.6107 |
Current Ratio | 1.437 |
Net Debt Paydown Yield | -0.02% |